399 related articles for article (PubMed ID: 18803833)
1. Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
Zurovac D; Tibenderana JK; Nankabirwa J; Ssekitooleko J; Njogu JN; Rwakimari JB; Meek S; Talisuna A; Snow RW
Malar J; 2008 Sep; 7():181. PubMed ID: 18803833
[TBL] [Abstract][Full Text] [Related]
2. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Zurovac D; Njogu J; Akhwale W; Hamer DH; Snow RW
Trop Med Int Health; 2008 Jan; 13(1):99-107. PubMed ID: 18291008
[TBL] [Abstract][Full Text] [Related]
3. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
Zurovac D; Ndhlovu M; Rowe AK; Hamer DH; Thea DM; Snow RW
BMJ; 2005 Oct; 331(7519):734. PubMed ID: 16195289
[TBL] [Abstract][Full Text] [Related]
4. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
[TBL] [Abstract][Full Text] [Related]
5. Changes in health workers' malaria diagnosis and treatment practices in Kenya.
Juma E; Zurovac D
Malar J; 2011 Jan; 10():1. PubMed ID: 21214892
[TBL] [Abstract][Full Text] [Related]
6. Quality of malaria case management at outpatient health facilities in Angola.
Rowe AK; de León GF; Mihigo J; Santelli AC; Miller NP; Van-Dúnem P
Malar J; 2009 Dec; 8():275. PubMed ID: 19954537
[TBL] [Abstract][Full Text] [Related]
7. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Tarimo DS; Malekela DA
East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
[TBL] [Abstract][Full Text] [Related]
8. Health worker performance in the management of paediatric fevers following in-service training and exposure to job aids in Kenya.
Wasunna B; Zurovac D; Bruce J; Jones C; Webster J; Snow RW
Malar J; 2010 Sep; 9():261. PubMed ID: 20849650
[TBL] [Abstract][Full Text] [Related]
9. Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya.
Zurovac D; Njogu J; Akhwale W; Hamer DH; Larson BA; Snow RW
Trop Med Int Health; 2008 Jun; 13(6):784-7. PubMed ID: 18482078
[TBL] [Abstract][Full Text] [Related]
10. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
[TBL] [Abstract][Full Text] [Related]
11. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Simba D; Kakoko D
Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
[TBL] [Abstract][Full Text] [Related]
13. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia.
Chanda P; Masiye F; Chitah BM; Sipilanyambe N; Hawela M; Banda P; Okorosobo T
Malar J; 2007 Feb; 6():21. PubMed ID: 17313682
[TBL] [Abstract][Full Text] [Related]
14. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
Ajayi IO; Falade CO; Olley BO; Yusuf B; Gbotosho S; Iyiola T; Olaniyan O; Happi C; Munguti K; Pagnoni F
BMC Health Serv Res; 2008 Jun; 8():119. PubMed ID: 18513447
[TBL] [Abstract][Full Text] [Related]
15. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India.
Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N
J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849
[TBL] [Abstract][Full Text] [Related]
16. Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
Nyandigisi A; Memusi D; Mbithi A; Ang'wa N; Shieshia M; Muturi A; Sudoi R; Githinji S; Juma E; Zurovac D
PLoS One; 2011; 6(9):e24781. PubMed ID: 21935464
[TBL] [Abstract][Full Text] [Related]
17. Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
Staedke SG; Mwebaza N; Kamya MR; Clark TD; Dorsey G; Rosenthal PJ; Whitty CJ
Lancet; 2009 May; 373(9675):1623-31. PubMed ID: 19362361
[TBL] [Abstract][Full Text] [Related]
18. Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania.
Minzi O; Maige S; Sasi P; Ngasala B
Malar J; 2014 Jul; 13():267. PubMed ID: 25011682
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
[TBL] [Abstract][Full Text] [Related]
20. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
